pubmed.ncbi.nlm.nih.gov

Effect of Vitamin D supplementation on symptoms and C-reactive protein in migraine patients - PubMed

Effect of Vitamin D supplementation on symptoms and C-reactive protein in migraine patients

Tayebeh Mottaghi et al. J Res Med Sci. 2015 May.

Abstract

Background: Migarine is the most common headache around the world including Iran. In recent years, Vitamin D deficiency has been shown to a global health problem. A few studies have been determined inverse association between serum levels of Vitamin D with a headache. So, in this study, we investigated the effect of Vitamin D supplementation on symptoms and C-reactive protein (CRP) among patients with migraine.

Materials and methods: This study was randomized, double-blind, and controlled-placebo clinical trial. Sixty-five migraine patients aged 10-61 years were included for analysis. Vitamin D was administrated for 10 weeks with 50,000 IU dosage of Vitamin D per week. Multivariate analysis of covariate and univariate analysis of covariate were done to determine the effects of Vitamin D supplementation on symptoms, including severity, duration, frequency of headache, and the headache diary result (HDR).

Results: Mean headache frequency and HDR had significant difference among two groups (5.9 ± 7.0 vs. 7.0 ± 6.0, P = 0.06 and 85.0 ± 134.2 vs. 132.1 ± 147.1, P = 0.04). But, a mean difference of headache frequency was marginally significant (P = 0.06). These values were lower among the intervention group compared to placebo group. The association was not observed between CRP with migraine disease.

Conclusion: In this study, we shown Vitamin D supplementation may be useful in decreasing frequency of headache attacks and HDR among patients with migraine.

Keywords: C-reactive protein; Vitamin D; headache; migraine.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: No conflict of interests.

Similar articles

Cited by

References

    1. Lateef TM, Cui L, Nelson KB, Nakamura EF, Merikangas KR. Physical comorbidity of migraine and other headaches in US adolescents. J Pediatr. 2012;161:308–13.e1. - PMC - PubMed
    1. Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, et al. Prevalence of primary headaches in Germany: Results of the German Headache Consortium Study. J Headache Pain. 2012;13:215–23. - PMC - PubMed
    1. Battista J, Badcock DR, McKendrick AM. Migraine increases centre-surround suppression for drifting visual stimuli. PLoS One. 2011;6:e18211. - PMC - PubMed
    1. Inaloo S, Dehghani SM, Farzadi F, Haghighat M, Imanieh MH. A comparative study of celiac disease in children with migraine headache and a normal control group. Turk J Gastroenterol. 2011;22:32–5. - PubMed
    1. Headache Disorders. [Last accessed on 2004 Mar]. Available from: http://www.who.int/mediacentre/factsheets/fs277/en/